Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
4
×
crispr
4
×
life sciences
national blog main
san francisco blog main
deals
medical devices
national top stories
san francisco top stories
startups
abbvie
allergan
alzheimer's disease
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
editas medicine
eli lilly
fda
indiana blog main
indiana top stories
investing
ipo
lyra therapeutics
mammoth biosciences
national
new york blog main
new york top stories
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
rare diseases
san diego blog main
san diego top stories
seattle blog main
What
bio
develop
life
mammoth
roundup
science
abbvie
alliance
available
bails
based
big
biosciences
biotech
black
brand
bridgebio
capital
car
cas
cheaper
companies
continue
crispr
debut
diagnostics
diamond
diamond’s
drugs
editas
editing
emerges
exits
expects
experimental
faster
firm
gene
genetic
grab
Language
unset
4
×
Current search:
crispr
×
unset
×
" boston top stories "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More